2013
Subclavian Aneurysm Presenting with Massive Hemoptysis: A Case Report and Review of the Literature
Brown HA, Aruny JE, Elefteriades JA, Sumpio BE. Subclavian Aneurysm Presenting with Massive Hemoptysis: A Case Report and Review of the Literature. International Journal Of Angiology 2013, 22: 069-074. PMID: 24436588, PMCID: PMC3699228, DOI: 10.1055/s-0033-1333862.Peer-Reviewed Original ResearchSubclavian aneurysmMassive hemoptysisMethicillin-resistant Staphylococcus aureus endocarditisAmplatzer II vascular plugEnd-stage renal diseaseLeft upper lobe bronchusCoronary artery bypassInternal mammary arterySubclavian artery aneurysmArtery bypass graftBright red bloodStage renal diseaseUpper lobe bronchusPast medical historyStaphylococcus aureus endocarditisChallenging clinical problemEndocardial pacing leadsArtery bypassMammary arteryCoronary angiographyLobe bronchusOpen repairRenal diseaseArtery aneurysmBypass graft
2009
Prevention of Lesion Recurrence in Endovascular Devices
Rochier A, Sumpio B. Prevention of Lesion Recurrence in Endovascular Devices. 2009, 431-447. DOI: 10.1007/978-1-4419-1387-6_30.Peer-Reviewed Original ResearchIliac arteryAutogenous bypass graftsMulticenter trialBypass graftLesion recurrenceEndovascular methodsStent placementFemoral arteryAtherosclerotic obstructionDrug AdministrationUS FoodAdequate conduitArteryEndovascular devicesInvasive surgeryStentsHuman arteriesFavorable resultsOptimal techniqueSuitable riskAngioplastyIliacPatientsSurgeryRecurrence
2000
Gender does not impact infrainguinal vein bypass graft outcome
Frangos S, Karimi S, Kerstein M, Harpavat M, Sumpio B, Roberts A, Gahtan V. Gender does not impact infrainguinal vein bypass graft outcome. Surgery 2000, 127: 679-686. PMID: 10840364, DOI: 10.1067/msy.2000.105859.Peer-Reviewed Original ResearchConceptsGraft patencySurvival rateMultivariate analysisInfrainguinal vein bypass graftsCox proportional hazards modelInfrainguinal occlusive diseaseLimb salvage rateVein bypass graftsBypass graft operationsProportional hazards modelLife-table analysisInfrainguinal vein bypassPercentage of womenMajor amputationGraft outcomePostoperative complicationsIncisional complicationsOcclusive diseasePostoperative outcomesLimb salvageRenal diseaseBypass graftPatient selectionVein graftsMorbidity rate
1993
Control of smooth muscle cell proliferation by psoralen photochemotherapy
Sumpio B, Phan S, Gasparro F, Deckelbaum L. Control of smooth muscle cell proliferation by psoralen photochemotherapy. Journal Of Vascular Surgery 1993, 17: 1010-1018. DOI: 10.1016/0741-5214(93)90671-8.Peer-Reviewed Original ResearchConceptsSmooth muscle cell proliferationMuscle cell proliferationSMC proliferationPsoralen photochemotherapyPeripheral vascular diseaseLong-term therapyCell proliferationInhibits SMC proliferationTrypan blue exclusionBypass graftDistal anastomosisBalloon angioplastyUVA photochemotherapyVascular diseaseIntimal hyperplasiaGrowth of SMCsBlue exclusionPhotochemotherapySMC viabilityTime courseProliferationUVADNA synthesisDaysAngioplastyControl of smooth muscle cell proliferation by psoralen photochemotherapy.
Sumpio B, Phan S, Gasparro F, Deckelbaum L. Control of smooth muscle cell proliferation by psoralen photochemotherapy. Journal Of Vascular Surgery 1993, 17: 1010-6; discussion 1016-8. PMID: 8505779, DOI: 10.1067/mva.1993.45747.Peer-Reviewed Original ResearchConceptsSmooth muscle cell proliferationMuscle cell proliferationSMC proliferationPsoralen photochemotherapyPeripheral vascular diseaseLong-term therapyCell proliferationInhibits SMC proliferationTrypan blue exclusionBypass graftDistal anastomosisBalloon angioplastyUVA photochemotherapyVascular diseaseIntimal hyperplasiaGrowth of SMCsBlue exclusionPhotochemotherapySMC viabilityTime courseProliferationUVADNA synthesisDaysAngioplasty